Immediate Impact
2 from Science/Nature 59 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Anand Pathak being referenced
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
2020
The efficacy and safety of paclitaxel injection concentrate for nano-dispersion (PICN) at two different doses versus paclitaxel albumin-stabilized nanoparticle formulation in subjects with metastatic breast cancer (MBC).
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Anand Pathak | 151 | 39 | 128 | 64 | 25 | 375 | |
| T Furukawa | 126 | 42 | 118 | 47 | 22 | 379 | |
| B.K. Amo-Takyi | 131 | 98 | 101 | 47 | 20 | 397 | |
| Αngeliki Andrikopoulou | 151 | 20 | 206 | 27 | 39 | 402 | |
| E D'Andrea | 147 | 14 | 109 | 78 | 22 | 397 | |
| SHOJIRO YANO | 121 | 83 | 75 | 36 | 32 | 405 | |
| Victor G. Gian | 84 | 24 | 152 | 36 | 25 | 434 | |
| C Rimbaut | 131 | 45 | 74 | 36 | 25 | 380 | |
| Cumhur Gökhan Ekmekçi | 192 | 47 | 34 | 47 | 26 | 407 | |
| Brian M.J. Cantwell | 127 | 17 | 236 | 32 | 21 | 369 | |
| V. K. Vaitkevicius | 87 | 53 | 163 | 68 | 22 | 436 |
All Works
Login with ORCID to disown or claim papers
Loading papers...